How do I track levodopa response so the neurologist can actually use it?

Published by Unseen Progress, an independent publisher of caregiver research. Last reviewed 2026-05-10. Part of the Parkinson's caregiver research overview.

Short answer. A neurologist sees a person with Parkinson's for twenty minutes every three to six months. The caregiver sees them across thousands of medication cycles. The clinical literature on Parkinson's treatment optimisation is unanimous that medication adjustments depend on accurate longitudinal data, and caregiver-kept logs are the most usable form of that data when they follow a small number of conventions (Goetz et al., 2008; Bloem et al., 2021).

Why the appointment alone cannot tell the neurologist what's happening

A movement disorder appointment captures one cross-section of one day, often during a peak on-period, with the person performing in front of the specialist. The MDS-UPDRS Part IV (Motor Complications) explicitly asks the patient and caregiver about the proportion of waking hours spent in off, the proportion with troublesome dyskinesia, and the predictability of the off — none of which can be observed in the appointment itself (Goetz et al., 2008).

The Schrag et al. (2006) caregiver-burden literature and the Olanow / Watts / Koller treatment-algorithm work both highlight that the highest-leverage moment in PD management — the medication adjustment — depends on data that lives in the caregiver's memory and rarely makes it onto the chart unaided. Most caregivers walk into the appointment, lose their thread under pressure, and walk out with a regimen that addresses the symptom most visible in the room rather than the pattern across the week.

What "good" looks like — the minimum dataset a neurologist can use

A movement disorder specialist asked what they actually want from caregiver tracking will typically converge on the following short list:

1. Dose times for the past week — exact times, including any missed or delayed doses. 2. Approximate hours of good on-time per day, averaged across the week. 3. Approximate hours of off-time per day, with a note on whether the off-periods are predictable (always 3–4 hours after a dose) or unpredictable (random). 4. Presence of dyskinesia, when it occurs (peak-dose, biphasic, off-period), and whether it is troublesome (interferes with activity) or not. 5. First symptom of wearing-off — the symptom that consistently appears first as a dose wears off (often a non-motor symptom: anxiety, fatigue, mild tremor, soft voice). 6. Non-motor symptoms changing in step with the cycle — mood, cognition, autonomic symptoms. 7. Sleep — number of awakenings, presence of acting out dreams, daytime sleepiness. 8. Falls or near-falls in the past 30 days, with circumstances (transitions, off-period, dyskinesia, orthostasis).

This is fundamentally what the MDS-UPDRS Parts I, II, and IV try to capture. A caregiver who arrives with a one-page summary covering these points changes the quality of the appointment. The specialist can then spend the visit titrating the regimen rather than reconstructing it.

The structured 14-day log — what to write down

The simplest format that produces usable data is a single column-per-day grid:

  • One row per dose (time, drug, dose).
  • One row per meal containing protein.
  • A 30-minute "state check" running through the day with one of four codes: OFF (symptoms uncontrolled), ON (symptoms controlled), ON-D (controlled but with dyskinesia), or MIX (transition).
  • A bedtime row noting sleep quality and any night-time events.
  • A short free-text box for the day's standout — a fall, a particularly hard off, an unusually fluent stretch.

Two weeks of this is usually enough to reveal the dominant fluctuation pattern (predictable wearing-off, unpredictable on/off, delayed-on, dose failures) and to give the neurologist the input needed for the next adjustment.

The Parkinson's Foundation publishes a free symptom diary in this format. Apps like StrivePD, mPower, and Parkinson's Disease Tracker collect similar data — primarily for the patient and clinical team, less for the caregiver's own decision-making.

Reading the log — what patterns mean clinically

A caregiver does not need to make medication recommendations. But understanding what the log is showing prevents both unnecessary alarm and unnecessary delay.

  • Wearing-off appearing 3–3.5 hours after a 4-hour dose interval suggests the interval is now too long for the current dose; shortening intervals or extending the dose with a COMT inhibitor (entacapone, opicapone) is one of the standard responses (Olanow et al., 2000; AAN guidelines).
  • Delayed-on after high-protein meals suggests dietary timing is the issue, not the dose itself. Adjusting the meal timing or the levodopa-to-meal interval is often more effective than dose changes.
  • Sudden, unpredictable off-periods without obvious dose relationship may suggest gastric absorption problems (gastroparesis is common in PD) or progression toward a fluctuation pattern that responds better to long-acting formulations or device-aided therapy.
  • Peak-dose dyskinesia (involuntary movements appearing 60–90 minutes after a dose) typically suggests the peak level is too high; smaller, more frequent doses, or a long-acting formulation, may help.
  • Biphasic dyskinesia (movements as the dose comes on and again as it wears off) is harder to manage and often a marker for advanced disease and a candidate for DBS evaluation.
  • Morning akinesia (severe immobility on waking) often responds to dispersible levodopa or a bedtime long-acting agonist.

These are not prescriptions; they are the language to bring to the appointment so that the conversation can be specific.

Non-motor symptoms in the log

The Chaudhuri et al. (2006) and Schrag et al. (2015) work makes clear that non-motor symptoms — depression, apathy, cognitive fluctuation, sleep disruption, autonomic dysfunction, pain — drive more caregiver burden than motor symptoms and are systematically under-detected in standard appointments. A caregiver log that includes a single daily score on mood, cognitive clarity, and energy adds dimensions the motor exam cannot capture.

The Non-Motor Symptoms Questionnaire (NMSQuest) is the validated short instrument for surveying non-motor symptoms; an annual run-through with the neurologist using a caregiver-completed NMSQuest catches problems that otherwise persist for years untreated.

What to bring to the appointment

A workable preparation has three pieces: a one-page summary of the past month's dominant patterns, the most recent two weeks of the structured log, and a list of three to five questions that arose from the log. Most movement disorder appointments are short; a written list prevents the loss of half the agenda to the chair-rise test and the finger-tapping observations.

A practical question list looks like:

  • "Off-time has gone from 3 to 5 hours a day across the past month. Is this dose timing or progression?"
  • "She's getting peak-dose dyskinesia 60 minutes after the noon dose. Should we split the dose?"
  • "He's having delayed-on after lunch on protein-heavy days. What should we change first — the meal or the dose timing?"
  • "Sleep is fragmented and she's acting out dreams. Should we add a referral to sleep medicine?"

What the research suggests doing

  • Keep a 14-day structured log before any non-emergency adjustment conversation.
  • Use the same time-and-state format every time so the data is comparable visit-to-visit.
  • Track non-motor symptoms alongside motor symptoms; they often drive treatment decisions more than the motor record.
  • Bring a one-page summary, not the full log, into the room — and the full log on the phone in case the specialist asks.
  • Treat the log as the input to a conversation, not as a self-prescription. The pattern is the caregiver's contribution; the regimen is the specialist's.

Related questions

References

  • Goetz, C. G., et al. (2008). MDS-UPDRS. Movement Disorders, 23(15), 2129–2170.
  • Olanow, C. W., Watts, R. L., & Koller, W. C. (2000). Algorithm for the management of Parkinson's disease. Neurology, 56(11 Suppl 5), S1–S88.
  • Chaudhuri, K. R., Healy, D. G., & Schapira, A. H. V. (2006). Non-motor symptoms of Parkinson's disease. The Lancet Neurology, 5(3), 235–245.
  • Schrag, A., Hovris, A., Morley, D., Quinn, N., & Jahanshahi, M. (2006). Caregiver-burden in Parkinson's disease. Parkinsonism & Related Disorders, 12(1), 35–41.
  • Bloem, B. R., Okun, M. S., & Klein, C. (2021). Parkinson's disease. The Lancet, 397(10291), 2284–2303.

Additional reading: the Michael J. Fox Foundation symptom diary; the Parkinson's Foundation Aware in Care kit; AAN PD practice guidelines.

---

Unseen Progress publishes long-form caregiver research and builds research-backed daily trackers for the families covered. See the full Parkinson's caregiver research overview for the complete framework.